Rosanna Tavella

ORCID: 0000-0002-4869-465X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Cardiac Health and Mental Health
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiovascular Health and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrest and Resuscitation
  • Cardiovascular Issues in Pregnancy
  • Cardiac Arrhythmias and Treatments
  • Telemedicine and Telehealth Implementation
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Heart Rate Variability and Autonomic Control
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pain Management and Treatment
  • Stroke Rehabilitation and Recovery
  • Blood Pressure and Hypertension Studies
  • Peripheral Artery Disease Management
  • Cardiac electrophysiology and arrhythmias
  • Health Systems, Economic Evaluations, Quality of Life
  • Congenital Heart Disease Studies
  • Sex and Gender in Healthcare
  • Emergency and Acute Care Studies

The University of Adelaide
2016-2025

Central Adelaide Local Health Network
2016-2025

Basil Hetzel Institute
2016-2025

Queen Elizabeth Hospital
2014-2024

Women's and Children's Health Network
2015-2024

SA Health
2013-2023

University of South Australia
2023

Queen Elizabeth Hospital
2014-2022

Health Net
2015-2022

New South Wales Department of Health
2019

Objectives: To characterise management of suspected acute coronary syndrome (ACS) in Australia and New Zealand, to assess the application recommended therapies according published guidelines. Design, setting patients: All patients hospitalised with or confirmed ACS between 14 27 May 2012 were enrolled from participating sites which identified through public records health networks. Descriptive logistic regression analysis was performed. Main outcome measures: Rates guideline-recommended...

10.5694/mja12.11854 article EN The Medical Journal of Australia 2013-08-01

Background: Contemporary ST-segment–elevation myocardial infarction management involves primary percutaneous coronary intervention, with ongoing studies focusing on infarct size reduction using ancillary therapies. N-acetylcysteine (NAC) is an antioxidant reactive oxygen species scavenging properties that also potentiates the effects of nitroglycerin and thus represents a potentially beneficial therapy in intervention. The NACIAM trial (N-acetylcysteine Acute Myocardial Infarction) examined...

10.1161/circulationaha.117.027575 article EN Circulation 2017-06-21

Abstract Aims The prognosis of patients with MINOCA (myocardial infarction non-obstructive coronary arteries) is poorly understood. We examined major adverse cardiac events (MACE) defined as all-cause mortality, re-hospitalization for acute myocardial (AMI), heart failure (HF), or stroke 12-months post-AMI in versus AMI obstructive artery disease (MICAD). Methods and results Multicentre, observational cohort study (≥65 years) from the National Cardiovascular Data Registry CathPCI (July...

10.1093/eurheartj/ehz403 article EN European Heart Journal 2019-05-24

Objective: To evaluate the impact of regionalised Integrated Cardiovascular Clinical Network (ICCNet) on 30-day mortality among patients with myocardial infarction (MI) in an Australian rural setting. Design, setting and patients: An integrated cardiac support network incorporating standardised risk stratification, point-of-care troponin testing cardiologist-supported decision making was progressively implemented non-metropolitan areas South Australia from 2001 to 2008. Hospital...

10.5694/mja13.10645 article EN The Medical Journal of Australia 2014-02-01

Approximately 30% of patients undergoing coronary angiography for chest pain have insignificant artery disease (ICAD). The subsequent health status these is largely unknown. current study was a cross-sectional, longitudinal comparison outcomes 12 months following angiography, in cohort with stable and ICAD to: (i) significant (CAD) (ii) healthy control cohort.Patients elective were recruited classified as CAD (coronary stenosis ≥50%) or ICAD. Clinical health-related quality-of-life (HRQoL)...

10.1093/ehjqcco/qcv034 article EN European Heart Journal - Quality of Care and Clinical Outcomes 2016-01-06

BackgroundDespite the highest levels of evidence on cardiac rehabilitation (CR) effectiveness, its translation into practice is compromised by low participation.AimThis study aimed to investigate CR utilisation and effectiveness in South Australia.MethodsThis retrospective cohort used data linkage clinical administrative databases from 2016 2021 assess association between (no received, commenced without completing, or completed) composite primary outcome (mortality/cardiovascular...

10.1016/j.hlc.2024.01.018 article EN cc-by Heart Lung and Circulation 2024-03-05

Background/Objectives: The diagnosis of coronary artery spasm (CAS) frequently requires invasive provocation testing, typically utilising acetylcholine (ACh). Although the left (LCA) is routinely assessed as a part testing protocol, assessment right (RCA) often avoided since it insertion temporary pacing wire. We sought to compare prevalence inducible CAS in LCA and RCA, among patients with undergoing multivessel ACh. Methods: A local multi-institutional ANOCA (angina non-obstructive...

10.3390/jcm14041355 article EN Journal of Clinical Medicine 2025-02-18

Abstract Background In patients undergoing invasive coronary angiography for the investigation of angina, management pathways obstructive artery disease (CAD) are well described, whereas clinical and diagnostic journey with ANOCA has largely been inferred, as there is limited quantitative data. Objectives To compare versus Obstructive CAD, particularly in relation to (i) presentation (ii) assessment, (iii) 12 month patient-reported outcome measures (PROMs) (iv) three year composite MACE...

10.1093/ehjqcco/qcaf012 article EN cc-by-nc European Heart Journal - Quality of Care and Clinical Outcomes 2025-02-24

Introduction Refractory vasospastic angina (VSA) includes patients with disabling despite maximally tolerated calcium channel blocker and nitrate therapy. Randomised clinical trial evidence confirms the efficacy of cilostazol in refractory VSA, yet its use real-world practice is limited. This study evaluated impact therapy on patient-reported outcomes VSA. Methods Between June 2016 May 2022, 15 consecutive VSA were initiated (50mg twice daily), baseline 3-month responses assessed via Seattle...

10.1159/000544943 article EN cc-by-nc Cardiology 2025-02-27

Non-ST elevation myocardial infarction (NSTEMI) has higher post-discharge mortality than ST-elevation (STEMI). Prognosis worsens in those with multivessel coronary disease (MVD). However, information about the prevalence and extent of MVD NSTEMI is limited, turn limiting insights into optimal treatment strategies. This study aimed to define MVD, preferred strategies predictors a real-world population.The Coronary Angiogram Database South Australia (CADOSA) was used identify consecutive...

10.21037/cdt-21-518 article EN Cardiovascular Diagnosis and Therapy 2022-02-01

Objectives: To assess differences in the rates of angiography and subsequent revascularisation for Aboriginal non-Aboriginal South Australians who presented with an acute coronary syndrome (ACS); to explore reasons any observed differences. Design: Analysis administrative data logistic regression modelling relationship between status decision undertake diagnostic angiography. A detailed medical record review admissions was subsequently undertaken. Setting: Emergency ACS SA cardiac...

10.5694/mja16.00445 article EN The Medical Journal of Australia 2016-09-01
Coming Soon ...